NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Some of the world’s largest technology companies swiftly quashed a California legislative measure that pitted giants like Apple Inc. and Google against smaller rivals, a display of their immense political influence in their home state.Read More